Logo image of CTOR

CITIUS ONCOLOGY INC (CTOR) Stock Analyst Ratings

USA - NASDAQ:CTOR - US17331Y1091 - Common Stock

2 USD
+0.18 (+9.89%)
Last: 9/26/2025, 8:00:00 PM
1.99 USD
-0.01 (-0.5%)
After Hours: 9/26/2025, 8:00:00 PM
Buy % Consensus

43

ChartMill assigns a Buy % Consensus number of 43% to CTOR. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 3.06. This target is 53% above the current price.
CTOR was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CTOR.
In the previous month the buy percentage consensus was at a similar level.
CTOR was analyzed by 6 analysts. More opinions would make the average more meaningful.

Related screens

CTOR Historical Analyst RatingsCTOR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -6 -5 -4 -3 -2 -1 0 2 4 6

Price Target & Forecast

Price Low Median Mean High 2.003.033.063.063.15 - 51.50% 53.00% 53.00% 57.50%

Related screens

CTOR Current Analyst RatingCTOR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-09-23 Maxim Group Upgrade Hold -> Buy
2025-05-23 Maxim Group Downgrade Buy -> Hold
2024-11-27 Maxim Group Initiate Buy
2024-08-13 EF Hutton Maintains Buy -> Buy